Lesson plan

ACE experiment

The Antiproton Cell Experiment (ACE), AD-4, at the Antiproton Decelerator facility at CERN, Geneva, was started in 2003. It aims to assess fully the effectiveness and suitability of antiprotons for cancer therapy. In 1947, Robert R. Wilson introduced particle beam therapy, as heavy charged particles tend to have a finite range in water (therefore, in the human body) and an advantageous depth-dose profile compared to that of electrons or X-rays. Following such ideas, the hunt for an 'ideal' particle for cancer therapy began. And ACE collaboration was set up to measure and compare the relative biological effectiveness of protons and antiprotons. The results from ACE experiment showed that antiprotons required to break down the tumor cells were four times less than the number of protons required. The effect on healthy tissues due to antiprotons was significantly less. Although the experiment ended in 2013, further research and validation still continue, owing to the long procedures of bringing in novel medical treatments.

Back to article

Article summary

The Antiproton Cell Experiment (ACE), AD-4, at the Antiproton Decelerator facility at CERN, Geneva, was started in 2003. It aims to assess fully the effectiveness and suitability of antiprotons for cancer therapy. In 1947, Robert R. Wilson introduced particle beam therapy, as heavy charged particles tend to have a finite range in water (therefore, in the human body) and an advantageous depth-dose profile compared to that of electrons or X-rays. Following such ideas, the hunt for an 'ideal' particle for cancer therapy began. And ACE collaboration was set up to measure and compare the relative biological effectiveness of protons and antiprotons. The results from ACE experiment showed that antiprotons required to break down the tumor cells were four times less than the number of protons required. The effect on healthy tissues due to antiprotons was significantly less. Although the experiment ended in 2013, further research and validation still continue, owing to the long procedures of bringing in novel medical treatments.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.